VTA-300

N/A

Report date: 2023/10/18 17:51:08

Base Information

Drug NameVTA-300
Drug Alias NameVTA-300
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/Indicationsloss of tissue stem cellsRare Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesVita Therapeutics IncCambrian Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesCambrian Biopharma IncVita Therapeutics Inc
Inactive CompaniesN/A
Active Indicationsloss of tissue stem cellsRare Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A